Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers.

Michel L, Grasmuck C, Charabati M, Lécuyer MA, Zandee S, Dhaeze T, Alvarez JI, Li R, Larouche S, Bourbonnière L, Moumdjian R, Bouthillier A, Lahav B, Duquette P, Bar-Or A, Gommerman JL, Peelen E, Prat A.

Sci Transl Med. 2019 Nov 13;11(518). pii: eaaw0475. doi: 10.1126/scitranslmed.aaw0475.


Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.

Dhaeze T, Lachance C, Tremblay L, Grasmuck C, Bourbonnière L, Larouche S, Saint-Laurent O, Lécuyer MA, Rébillard RM, Zandee S, Prat A.

JCI Insight. 2019 Mar 21;4(6). pii: 124885. doi: 10.1172/jci.insight.124885. eCollection 2019 Mar 21.


CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.

Dhaeze T, Tremblay L, Lachance C, Peelen E, Zandee S, Grasmuck C, Bourbonnière L, Larouche S, Ayrignac X, Rébillard RM, Poirier J, Lahav B, Duquette P, Girard M, Moumdjian R, Bouthillier A, Larochelle C, Prat A.

Cell Mol Immunol. 2019 Jul;16(7):652-665. doi: 10.1038/s41423-018-0198-5. Epub 2019 Jan 11.


Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis.

Dhaeze T, Hellings N.

Crit Rev Immunol. 2016;36(6):511-522. doi: 10.1615/CritRevImmunol.2017019850.


Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.

Dhaeze T, Peelen E, Hombrouck A, Peeters L, Van Wijmeersch B, Lemkens N, Lemkens P, Somers V, Lucas S, Broux B, Stinissen P, Hellings N.

J Immunol. 2015 Aug 1;195(3):832-40. doi: 10.4049/jimmunol.1500759. Epub 2015 Jun 12.


Humoral autoimmunity: a failure of regulatory T cells?

Dhaeze T, Stinissen P, Liston A, Hellings N.

Autoimmun Rev. 2015 Aug;14(8):735-41. doi: 10.1016/j.autrev.2015.04.006. Epub 2015 Apr 23. Review.


Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.

Claes N, Dhaeze T, Fraussen J, Broux B, Van Wijmeersch B, Stinissen P, Hupperts R, Hellings N, Somers V.

PLoS One. 2014 Oct 31;9(10):e111115. doi: 10.1371/journal.pone.0111115. eCollection 2014.

Supplemental Content

Loading ...
Support Center